Cardio Diagnostics Holdings, Inc.
$1.42+3.65%(+$0.05)
TickerSpark Score
53/100
75
Valuation
20
Profitability
55
Growth
84
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CDIO research report →
52-Week Range6% of range
Low $0.97
Current $1.42
High $7.91
Companycardiodiagnosticsinc.com
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test.
- CEO
- Meeshanthini V. Dogan
- IPO
- 2022
- Employees
- 13
- HQ
- Chicago, IL, US
Price Chart
-70.17% · this period
Valuation
- Market Cap
- $2.63M
- P/E
- -0.61
- P/S
- 158.86
- P/B
- 0.45
- EV/EBITDA
- 0.62
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -2512.09%
- Op Margin
- -40074.58%
- Net Margin
- -40152.50%
- ROE
- -78.82%
- ROIC
- -70.35%
Growth & Income
- Revenue
- $14.82K · -57.51%
- Net Income
- $-6,498,167 · 22.49%
- EPS
- $-3.71 · 60.11%
- Op Income
- $-6,484,078
- FCF YoY
- -9.58%
Performance & Tape
- 52W High
- $7.91
- 52W Low
- $0.97
- 50D MA
- $2.11
- 200D MA
- $3.06
- Beta
- 2.26
- Avg Volume
- 1.14M
Get TickerSpark's AI analysis on CDIO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 31, 26 | Fung Peter K | other | 3,205 |
| Mar 31, 26 | Betts Wendy J | other | 3,205 |
| Mar 31, 26 | Intrater James | other | 3,205 |
| Mar 31, 26 | Burton Paul Frederick | other | 3,205 |
| Dec 31, 25 | Fung Peter K | other | 2,306 |
| Dec 31, 25 | Betts Wendy J | other | 2,306 |
| Dec 31, 25 | Intrater James | other | 2,306 |
| Dec 31, 25 | Burton Paul Frederick | other | 2,306 |
| Sep 30, 25 | Fung Peter K | other | 1,559 |
| Sep 30, 25 | Betts Wendy J | other | 1,559 |
Our CDIO Coverage
We haven't published any research on CDIO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CDIO Report →Similar Companies
ADXN-3.14%
Addex Therapeutics Ltd
$6.78
BCLI+0.78%
Brainstorm Cell Therapeutics Inc.
$0.72
NRSN+6.29%
NeuroSense Therapeutics Ltd.
$0.81
MTNB+14.52%
Matinas BioPharma Holdings, Inc.
$0.64
CELZ+3.65%
Creative Medical Technology Holdings, Inc.
$2.27
ADIL+14.08%
Adial Pharmaceuticals, Inc.
$2.35
RADX-1.29%
Radiopharm Theranostics Limited
$4.58
TCRT-4.00%
Alaunos Therapeutics, Inc.
$2.40